2016
DOI: 10.1021/acs.oprd.6b00253
|View full text |Cite
|
Sign up to set email alerts
|

Development of a Control Strategy for a Final Intermediate to Enable Impurities Control

Abstract: This manuscript describes the development of a control strategy for impurities in the final intermediate step of the asunaprevir drug substance utilizing the concepts outlined in the International Conference on Harmonisation guidelines (ICH Q8 (R2), Q9, Q10, and Q11). Detailed mechanistic understanding enabled the construction of a kinetic model that was used in conjunction with a process risk assessment and well-defined quality attributes to guide the development of the reaction design space. Implementation o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 7 publications
0
6
0
Order By: Relevance
“…As a relevant example, scientists at Bristol Myers-Squibb developed a DS approach to manufacture asunaprevir (to treat chronic hepatitis C infection). [22] In this case, once the impurities and the critical factors were determined, the dynamic model of DS was built through a critical assessment of the elementary step kinetics, cross checked, and validated with several relevant experiments. The system of study involves the interaction of the polyfunctional alcohol derivative 1 with α-haloisoquinoline 2 in an aromatic nucleophilic substitution, using a strong base to generate the alkoxide reactive intermediate (Figure 2A).…”
Section: Process Chemistrymentioning
confidence: 99%
“…As a relevant example, scientists at Bristol Myers-Squibb developed a DS approach to manufacture asunaprevir (to treat chronic hepatitis C infection). [22] In this case, once the impurities and the critical factors were determined, the dynamic model of DS was built through a critical assessment of the elementary step kinetics, cross checked, and validated with several relevant experiments. The system of study involves the interaction of the polyfunctional alcohol derivative 1 with α-haloisoquinoline 2 in an aromatic nucleophilic substitution, using a strong base to generate the alkoxide reactive intermediate (Figure 2A).…”
Section: Process Chemistrymentioning
confidence: 99%
“…Another approach for the definition of a design space that is typically more resource-intensive is based on kinetic and mechanistic investigations; it is described in ICH Q11 and has been reported in the literature …”
Section: Statistical Design Of Experimentsmentioning
confidence: 99%
“…This is accomplished by having a solid understanding of the chemistry and processes and knowing the origin of and being able to control the impurities formed in the synthetic route. 1 The process control strategy, a specific and well-defined set of parameters, is developed to ensure product quality. 2 Across the synthetic sequence, impurity formation is governed by the chemistry undertaken, the quality of reagents, and reaction parameters such as temperature and concentration.…”
Section: ■ Introductionmentioning
confidence: 99%
“…For the commercial manufacturing of a drug substance, ensuring quality, patient safety, and uninterrupted drug supply are paramount. This is accomplished by having a solid understanding of the chemistry and processes and knowing the origin of and being able to control the impurities formed in the synthetic route . The process control strategy, a specific and well-defined set of parameters, is developed to ensure product quality .…”
Section: Introductionmentioning
confidence: 99%